Veeva Systems and Amgen Collaborate to Enhance Clinical Trials

Veeva Systems has announced a collaboration with Amgen to enhance clinical trial innovation, announced in a press release. Amgen will employ the Veeva Clinical Platform to streamline and identify efficiencies across the clinical trial process, aiming to accelerate the development of new medicines for patients with serious diseases.

The collaboration will leverage advanced technology to improve end-to-end trial operations, as stated by Scott Skellenger, Amgen's senior vice president and chief information officer. Veeva's Clinical Platform will serve as the backbone for standard and connected processes, potentially speeding up the delivery of life-saving drugs.

Additionally, Veeva Business Consulting will support Amgen through implementation and change management, ensuring a smooth transition to the new platform. The Veeva Clinical Platform includes a comprehensive suite of tools designed to streamline clinical trials from start-up to close, automating data flow and enhancing trial efficiency.